自然周期与激素替代疗法作为排卵女性冻融胚胎移植子宫内膜准备的比较:COMPETE开放标签随机对照试验
COMPETE试验在西安单中心纳入902例月经规律拟行冻融胚胎移植女性,1:1随机接受自然周期或激素替代周期准备内膜。自然周期组活产率54.0%高于激素替代组43.0%(绝对差11.1个百分点,95%CI 4.6至17.5;RR 1.26,95%CI 1.10至1.44),流产率及产前出血率更低;但允许组间交叉限制直接效力评估。
要点
- 月经规律女性冻融胚胎移植,自然周期起始准备活产率54.0% vs 激素替代43.0%(RR 1.26,95%CI 1.10至1.44)。
- 自然周期组流产率(RR 0.61,95%CI 0.41至0.89)与产前出血率(RR 0.63,95%CI 0.42至0.93)低于激素替代组。
- 其他产科及围产结局两组无显著差异,但允许组间交叉限制自然周期与激素替代疗效的直接评估。
核心结论
- 月经规律行冻融胚胎移植女性,自然周期起始内膜准备策略活产率高于激素替代准备。
- 允许的组间交叉限制直接评估自然周期与激素替代疗效的确定性。
研究设计与样本
- 单中心、平行、开放标签随机对照试验,2020年12月至2022年12月于中国西安单个辅助生殖中心进行。
- 902例月经规律行体外受精并计划冻融胚胎移植的女性1:1随机分配至自然周期组(n=448)或激素替代组(n=454),采用网络电子数据采集系统随机化。
- 主要结局为首次冻融胚胎移植后活产率,按意向性分析原则分析,并报告全部随机分配女性的产科及围产结局。
主要发现
- 自然周期组101例因无排卵接受激素替代治疗,激素替代组29例因自发排卵接受自然周期治疗。
- 活产数自然周期组242例(54.0%)vs 激素替代组195例(43.0%),绝对差11.1个百分点(95%CI 4.6至17.5),RR 1.26(95%CI 1.10至1.44)。
- 流产率自然周期组低于激素替代组(RR 0.61,95%CI 0.41至0.89)。
- 产前出血率自然周期组低于激素替代组(RR 0.63,95%CI 0.42至0.93)。
- 其他产科及围产结局两组无显著差异。
关键数值与推荐
- 主要结局活产率:自然周期组54.0%(242/448)vs 激素替代组43.0%(195/454),绝对差11.1个百分点(95%CI 4.6至17.5),RR 1.26(95%CI 1.10至1.44)。
- 流产率:自然周期组低于激素替代组,RR 0.61(95%CI 0.41至0.89)。
- 产前出血率:自然周期组低于激素替代组,RR 0.63(95%CI 0.42至0.93)。
临床怎么用
- 月经规律行冻融胚胎移植女性,自然周期起始内膜准备策略活产率高于激素替代准备。
- 原文未据此给出推荐。
局限性
- 允许的组间交叉限制直接评估自然周期与激素替代疗效的确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Different endometrial preparation protocols are used prior to frozen-thawed embryo transfer (FET). Optimization of endometrial preparation protocols is mandatory to improve live birth rate and obstetric and perinatal outcomes. In the Comparison of Endometrial Preparation Protocols for Frozen Embryo Transfer (COMPETE) trial, our primary objective is to evaluate whether natural cycles (NCs) lead to a higher live birth rate after the first FET cycle compared to hormone replacement therapy (HRT) cycles in women with a regular ovulatory cycle. METHODS AND FINDINGS: We performed a single-center, parallel, open-label randomized controlled trial between December 2020 and December 2022 in a single assisted reproduction center in Xi'an, China. Women with a regular menstrual cycle undergoing in vitro fertilization (IVF) scheduled for FET were randomly assigned (1:1) to endometrial preparation in the NC or with HRT, using a web-based electronic data capture system. The primary outcome was live birth rate after the initial FET. The analysis was conducted based on the intention-to-treat principle. Obstetric and perinatal outcomes in all randomly assigned women were reported in this study. We randomly assigned 902 women to receive either NC (n = 448) or HRT (n = 454). In the NC group, 101 women received HRT because of no ovulation, while in the HRT group, 29 women received NC because of spontaneous ovulation. The number of live births was 242 (54.0%) in the NC group versus 195 (43.0%) in the HRT group (absolute difference, 11.1 percentage points, 95% CI 4.6 to 17.5; risk ratio (RR) 1.26, 95% CI 1.10 to 1.44). Miscarriage rates (RR 0.61, 95% CI 0.41 to 0.89) and the antepartum hemorrhage rates (RR 0.63, 95%CI 0.42 to 0.93) were lower in the NC group, with other obstetric and perinatal outcomes not significantly different. CONCLUSIONS: In women with a regular menstrual cycle undergoing FET, a strategy starting with NC endometrial preparation results in higher live birth rates than endometrial preparation with HRT. However, the permitted cross-over between arms limits certainty in directly assessing NC versus HRT efficacy. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR2000040640.
引用
- Liu X, Li W, Wen W, et al. Natural cycle versus hormone replacement therapy as endometrial preparation in ovulatory women undergoing frozen-thawed embryo transfer: The COMPETE open-label randomized controlled trial. PLoS Med. 2025. PMID: 40561125. doi:10.1371/journal.pmed.1004630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。